Star Combo Pharma Ltd (S66) — Cash Flow Reinvestment Rate
Star Combo Pharma Ltd (S66) has a Cash Flow Reinvestment Rate of 0.51x as of December 2025, reinvesting AU$295.53K (capex AU$295.53K ) from operating cash flow of AU$575.23K. Explore Star Combo Pharma Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Star Combo Pharma Ltd Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Star Combo Pharma Ltd across 6 annual periods. Also explore Star Combo Pharma Ltd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Star Combo Pharma Ltd (2016–2025)
Year-by-year capital reinvestment analysis for Star Combo Pharma Ltd. For live market cap and broader valuation context, see how much is Star Combo Pharma Ltd worth.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.03x | AU$393.72K | AU$11.94 Million | AU$393.72K | ▼ -99.0% |
| 2023 | 3.17x | AU$5.96 Million | AU$1.88 Million | AU$2.73 Million | ▼ -97.6% |
| 2022 | 130.24x | AU$11.35 Million | AU$87.11K | AU$7.29 Million | ▲ +192.1% |
| 2021 | 44.59x | AU$14.78 Million | AU$331.53K | AU$7.26 Million | ▲ +15817.9% |
| 2017 | 0.28x | AU$261.13K | AU$932.20K | AU$261.13K | ▼ -68.3% |
| 2016 | 0.88x | AU$1.15 Million | AU$1.30 Million | AU$1.15 Million | — |